MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents.
McDaniel NK, Cummings CT, Iida M, Hülse J, Pearson HE, Vasileiadi E, Parker RE, Orbuch RA, Ondracek OJ, Welke NB, Kang GH, Davies KD, Wang X, Frye SV, Earp HS, Harari PM, Kimple RJ, DeRyckere D, Graham DK, Wheeler DL.
McDaniel NK, et al. Among authors: vasileiadi e.
Mol Cancer Ther. 2018 Nov;17(11):2297-2308. doi: 10.1158/1535-7163.MCT-17-1239. Epub 2018 Aug 9.
Mol Cancer Ther. 2018.
PMID: 30093568
Free PMC article.